Key Points Rhythm Pharmaceuticals' lone approved product currently generates minimal sales.However, recent clinical progress ...

Baby boomer are often overlooked in discussions about the retail trader phenomenon. BI spoke to three who have been in the ...

SINGAPORE (Reuters) -Singapore's central bank will place S$1.1 billion ($856.36 million) with three asset managers as part of ...

This Artificial Intelligence Stock Has Beaten the Market in 9 of the Past 10 Years. And It's On Track to Do It Again in 2025.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Over the last two years, investing has gained popularity, with nearly two-thirds of Americans owning stocks. If you'd like to ...

Despite the current market optimism, relying on economic headlines for investment decisions can prove harmful in the long run ...

Markets shrugged off tariff and Middle East fears while earnings held up. See why Davenport thinks equities remain investable ...

High P/E ratios jeopardize future stock returns. Learn why TDFs near retirement carry risks and explore safer assets like ...

With Wall Street's surge to record highs, the U.S. stock market looks nearly as expensive as ever, and investors are debating ...

Oppenheimer has initiated coverage on Affirm Holdings (NASDAQ:AFRM) with an Outperform rating and a $80 price target, ...

Jay Bowen, head of the Tampa Fire & Police Pension fund, explains how an ultralong-term focus can deliver through thick and ...